Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lombard, D. B.
Right arrow Articles by Guarente, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lombard, D. B.
Right arrow Articles by Guarente, L.
[Cancer Research 60, 2331-2334, May 1, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Nijmegen Breakage Syndrome Disease Protein and MRE11 at PML Nuclear Bodies and Meiotic Telomeres1

David B. Lombard and Leonard Guarente2

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139


    ABSTRACT
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Nijmegen breakage syndrome is a disease characterized by immunodeficiency, genomic instability, and cancer susceptibility. The gene product defective in Nijmegen breakage syndrome, p95, associates with two other proteins, MRE11 and RAD50. Here we demonstrate that in the absence of DNA damage, a portion of p95 and MRE11 is concentrated in PML nuclear bodies (NBs); MRE11 localization to the NBs is p95-dependent. In mammalian meiocytes, these proteins are specifically found at the telomeres. These results implicate the NBs in the maintenance of genomic stability and suggest that p95 and MRE11 may have roles in telomere maintenance in mammals, analogous to the role their homologues play in yeast.


    Introduction
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
NBS3 is a rare autosomal recessive disease. Affected individuals demonstrate delayed growth, microcephaly and mental retardation, variable immunodeficiency, gonadal dysfunction, and heightened susceptibility to cancer (1) . Cells explanted from individuals with this disease show genomic instability and sensitivity to IR, and lack an appropriate G1-S checkpoint in response to DNA damage (2, 3, 4, 5, 6) . The gene product defective in NBS is p95/Nibrin (hereinafter referred to as p95; Refs. 7, 8, 9 ). p95 is present in a complex with at least two other proteins, MRE11 and RAD50 (7) . Immunofluorescent localization of MRE11, RAD50, and p95 in mammalian cells provides additional evidence that these proteins respond to DNA damage (7 , 10) . In the absence of damage, these proteins have been reported to be diffusely spread throughout the nucleoplasm. After treatment of cells with IR, all three proteins colocalize in numerous nuclear dots, termed IR-induced foci. This response is absent in cells derived from NBS patients (7) . Experiments in yeast have implicated MRE11p and RAD50p in telomere maintenance (11 , 12) , although no telomeric role for these proteins has yet been demonstrated in mammals. Here we demonstrate that in the absence of irradiation, a fraction of p95 and MRE11 proteins is present at PML NBs in human mitotic cells. In addition, in mammalian meiocytes, these proteins are associated with telomeres.


    Materials and Methods
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Cells.
The wild-type human fibroblast WI38 and the NBS mutant cell line GM07166 were obtained from the Coriell Institute for Medical Research. Cells were grown in DMEM/15% heat-inactivated fetal bovine serum.

Meiotic Preparations.
Meiotic spreads were prepared by standard techniques (13) from testes removed from patients suffering from metastatic prostate cancer or chronic testicular pain, or from 129/BALB mice; indirect immunofluorescence was performed as for fibroblasts.

Immunofluorescence.
Two days prior to fixation, cells were split at varying dilutions onto multiwell slides (Cellpoint). Eight h prior to fixation, some slides were exposed to 10 Gy of IR and then returned to the incubator. WI38 and NBS fibroblasts were grown on the same slide to ensure uniformity of the culture conditions. Slides were prepared using the CSK and PFA fixation method as described previously (14 , 15) . Briefly, slides were washed once in PBS, washed for 30 s in CSK [100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM PIPES (pH 6.8)], incubated for 2 min in CSK containing 0.5% Triton X-100, washed briefly in CSK, and then fixed in PBS containing 4% PFA (Electron Microscopy Sciences) for 10 min.

Primary antibodies and their dilutions were as follows: rabbit anti-p95 and rabbit anti-MRE11 (gifts of J. Petrini, University of Wisconsin; a subsequent aliquot was the gift of D. Hill, Oncogene Research, Boston, MA), both 1:200 dilutions; mouse monoclonal anti-PML (Santa Cruz), 1:100 dilution; rabbit anti-SCP3 (gift of Christa Heyting), 1:200 dilution; 3H3 mouse anti-SCP3 (gift of Christa Heyting), 1:2 dilution; PX1 mouse anti-MRE11 (GeneTex), 1:50 dilution; mouse anti-TRF1 (gift of Titia deLange, Rockefeller University, NY), 1:5000 dilution. Slides were preincubated in blocking buffer [PBS containing 0.2% cold water fish skin gelatin (Sigma), 5% goat serum, and 0.2% Tween 20] for 30 min and then incubated for 1 h in blocking buffer containing the indicated concentration of primary antibody (or antibodies) at 37°C in a humidity chamber. Slides were then washed three times for 5 min each in PBS containing 0.2% Tween 20 and then incubated in blocking buffer plus secondary antibody. All secondary antibodies were purchased from Vector and were used at 1:100 dilution with the exception of Cy3 antirabbit and Cy3 antimouse, which were purchased from Amersham-Pharmacia and used at 1:200 dilution. Typical results are shown. In all cases, control experiments were performed using each primary alone and both secondaries to verify the results obtained in the double-labeling experiments.


    Results
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
p95 and MRE11 at PML NBs in Somatic Fibroblasts.
The p95 protein previously has been shown to be present throughout the nucleus of nonirradiated cells. However, if cells are initially subject to a hypotonic preextraction prior to fixation, which removes some of the diffuse nucleoplasmic p95, a fraction of p95 is concentrated in discrete nuclear structures in nonirradiated WI38 primary human fibroblasts (Fig. 1A)Citation . Using different preextraction protocols, others have also observed concentration of p95 in nuclear foci in nonirradiated cells.4 The appearance of these p95 foci is similar to PML NBs. Costaining of WI38 fibroblasts with rabbit anti-p95 and mouse anti-PML demonstrated that these p95 foci are NBs and that the p95 and PML staining patterns are virtually coincident in nonirradiated cells. Identical results were obtained using a human antiserum derived from a patient with primary biliary cirrhosis containing a high titer of antibodies directed against NBs (data not shown). Under these conditions, numerous other antigens, including Rad51, do not localize to NBs. With previously published immunofluorescence methods (7 , 10) , these p95 foci are nearly totally obscured by diffuse nuclear p95 staining (data not shown).



View larger version (67K):
[in this window]
[in a new window]
 
Fig. 1. Fractions of p95 and MRE11 localize to NBs. Shown are immunofluorescence images of wild-type primary human fibroblasts (WI38; A–C) or primary fibroblasts derived from an individual with NBS (GM07166; D) stained with anti-95 and anti-PML (A and B) or anti-MRE11 and anti-PML (C and D). In B, cells were irradiated with 10 Gy of IR from a 137Cs {gamma}-source and then allowed to recover for 8 h prior to fixation and staining. Extensive colocalization of focal p95 and NB staining are observed in WI38 cells (A). After {gamma}-irradiation, p95 appears in foci adjacent to some NBs (B, closed arrow) and also appears at additional foci not associated with NBs (B, open arrow). MRE11 is also present at NBS (C) in a p95-dependent manner (D).

 
DNA damage previously had been demonstrated to cause relocalization of RAD50, MRE11, and p95 to IR-induced foci (7 , 10) . WI38 fibroblasts were subjected to 10 Gy of {gamma}-irradiation and then fixed and stained 8 h later for the presence of p95 and PML (Fig. 1B)Citation . Some overlap was observed between p95 and PML in irradiated cells; however, a substantial amount of p95 was now observed adjacent to NBs (Fig. 1BCitation , closed arrow) or not associated with any apparent NBs (Fig. 1BCitation , open arrow). Overall, the p95 and PML patterns overlapped much less well in irradiated than in nonirradiated cells. Thus {gamma}-irradiation apparently causes redistribution of NB-associated p95 from NBs to larger domains in the nucleus, some of which abut NBs and some of which do not. Costaining with DAPI does not reveal any obvious relationship between these larger p95-containing domains and heterochromatic regions (Fig. 1B)Citation .

The localization of MRE11 was also assessed. A fraction of MRE11 also concentrated in NBs (Fig. 1C)Citation . In NBS cells, this focal MRE11 staining was absent, indicating that p95 is necessary for MRE11 localization to NBs in the absence of DNA damage (Fig. 1D)Citation .

p95 and MRE11 Proteins at Meiotic Telomeres.
Localization of p95 and MRE11 was assayed in both mouse and human meiotic spreads. Immunofluorescence was performed on mouse meiotic spreads using anti-p95 and a monoclonal antibody (3H3) directed against SCP3, a proteinaceous component of the presynaptic axial elements that remains associated with the synaptonemal complex following synapsis (16) . p95 labeling was predominantly seen associated with the very distal ends of the chromosomes (Fig. 2A)Citation . This labeling was seen in meiotic spreads in late leptonema, zygonema, and early pachynema (data not shown). To confirm these results, MRE11 localization was also determined in these preparations using a commercially available monoclonal antibody against MRE11 (PX1; GeneTex) and a polyclonal antisera directed against SCP3 (Fig. 2B)Citation . MRE11 is seen to be concentrated at the ends of chromosomes, although some chromosomes are also coated by MRE11 protein. We have observed MRE11 present on the synaptonemal complex of zero to four chromosomes per meiotic spread (Fig. 2B)Citation . We typically observe this MRE11 staining in late leptonema, but we do not know whether it correlates with the precise stage of the spread within meiosis.



View larger version (118K):
[in this window]
[in a new window]
 
Fig. 2. p95 and MRE11 localize to telomeres during murine and human meiosis. Murine meiotic spread was stained with rabbit anti-p95 and mouse anti-SCP3 (A) or mouse anti-MRE11 and rabbit anti-SCP3 (B). p95 and MRE11 are associated with the distal ends of the chromosomes; MRE11 also appears to coat some chromosomes. C, staining of human meiotic spread stained with rabbit anti-p95 and mouse anti-TRF1 confirms that these p95 foci represent telomeres.

 
The localization of p95 and MRE11 to the ends of chromosomes during meiosis suggests that these proteins may be preferentially associated with telomeres during this process. To confirm this hypothesis, p95 and the telomere binding protein TRF1 were colocalized in human meiotic spreads using rabbit anti-p95 and mouse anti-TRF1. The use of human meioses was necessitated by the fact that the anti-TRF1 antibody did not react with the murine protein. We confirmed that the p95 staining seen at the ends of chromosomes was at the telomeres (Fig. 2C)Citation . This pattern of p95 staining was never observed in mitotic cells. Similar overlap was observed when rabbit anti-MRE11 and anti-TRF1 were used (data not shown).


    Discussion
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
It previously had been observed that in the absence of genomic damage, the p95/MRE11/RAD50 complex is present throughout the nucleoplasm (7 , 10) . Using a preextraction technique to remove loosely bound p95 and MRE11, we now show that in the absence of irradiation, a fraction of these proteins is concentrated in NBs. After DNA damage, the NB-associated p95 and MRE11 partially relocalize from NBs into larger domains, many of which include the NBs. We also examined p95 and MRE11 localization in meiocytes. p95 and MRE11 proteins were found to be specifically present at the telomeres in mammalian meiosis.

Although NBs have been reported to be sites of accumulation of recently synthesized RNA (17) and of DNA replication (18) , a full description of their function is lacking. Several DNA viruses replicate preferentially near NBs, and many of these viruses encode proteins that disrupt NBs (19 , 20) . The recent demonstration that several proteins with roles in DNA recombination are present in NBs in cells that maintain their telomeres via a non-telomerase-dependent mechanism (21) suggests that NBs may, under some circumstances, play a role in recombination and in the maintenance of genome stability as well. The data presented in this work, together with our recent observation that two helicases of the RecQ family, BLM and RECQL, as well as a mutual interacting partner, TopoIII{alpha} (22) , are concentrated in NBs in primary cells, also support this hypothesis. Alternatively, the NBs may simply act as a reservoir for proteins that translocate and effect their functions in other locations throughout the cell. The observation that p95 and MRE11 relocalize in response to DNA damage supports this notion.

Although MRE11 and RAD50 proteins recently have been shown to be expressed during meiosis (23) , this is the first demonstration that p95 and MRE11 are specifically present on telomeres during this process; moreover, it is the first demonstration of any telomere-associated proteins in mammalian meiosis to our knowledge. Genetic studies in yeast suggest roles for MRE11p, RAD50p, and the p95 homologue Xrs2p in telomere maintenance (11 , 12) . It is possible that some fraction of these proteins usually associates with telomeres in differentiated somatic cells but cannot be visualized because of the high levels of these proteins elsewhere in the nucleus. Alternatively, the presence of these proteins at meiotic telomeres may represent a meiosis-specific function. In yeast, the RAD50p/MRE11p/Xrs2p complex has been proposed to process the ends of chromosomes in mitotic cells, rendering them suitable substrates for telomerase (11) . High levels of telomerase are found in the testes of M. musculus (24) . It is possible that the telomere-associated p95 and MRE11 we observed are responsible for processing the telomeres to a telomerase-accessible form. It will be interesting to study whether these proteins are also associated with telomeres in telomerase-positive somatic stem cells.


    ACKNOWLEDGMENTS
 
We thank the following individuals for their generous contributions of antibodies: J. Petrini for anti-p95 and anti-MRE11, D. Bloch for human anti-PML, D. Hill for an additional aliquot of anti-p95 and anti-MRE11, Christa Heyting for rabbit and mouse anti-SCP3, and Titia deLange for anti-TRF1. Most of the images shown in this work were generated at the Keck imaging facility, Whitehead Institute, MIT. We gratefully acknowledge F. Gertler for help with microscopy; J. Petrini, R. Marciniak, D. Bloch, B. Johnson, R. Jaenisch, and members of the Guarente and Jaenisch laboratories for helpful discussions; and B. Johnson and R. Marciniak for comments on the manuscript.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 D. B. L was supported by an MSTP grant to Harvard Medical School. The Guarente laboratory is supported by grants from the NIH, The Ellison Medical Foundation, The Seaver Institute, and The Howard and Linda Stern Foundation. Back

2 To whom requests for reprints should be addressed, at Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139. E-mail: leng{at}mit.edu Back

3 The abbreviations used are: NBS, Nijmegen breakage syndrome; IR, ionizing radiation; NB, nuclear body. Back

4 R. S. Maser and J. H. Petrini, personal communication. Back

Received 1/20/00. Accepted 3/20/00.


    REFERENCES
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 

  1. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet., 31: 635-662, 1997.[Medline]
  2. Taalman R. D., Jaspers N. G., Scheres J. M., de Wit J., Hustinx T. W. Hypersensitivity to ionizing radiation, in vitro, in a new chromosomal breakage disorder, the Nijmegen breakage syndrome. Mutat. Res., 112: 23-32, 1983.[Medline]
  3. Young B. R., Painter R. B. Radioresistant DNA synthesis and human genetic diseases. Hum. Genet., 82: 113-117, 1989.[Medline]
  4. Jongmans W., Vuillaume M., Chrzanowska K., Smeets D., Sperling K., Hall J. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation. Mol. Cell. Biol., 17: 5016-5022, 1997.[Abstract]
  5. Perez-Vera P., Gonzalez-del Angel A., Molina B., Gomez L., Frias S., Gatti R. A., Carnevale A. Chromosome instability with bleomycin and X-ray hypersensitivity in a boy with Nijmegen breakage syndrome. Am. J. Med. Genet., 70: 24-27, 1997.[Medline]
  6. Sullivan K. E., Veksler E., Lederman H., Lees-Miller S. P. Cell cycle checkpoints and DNA repair in Nijmegen breakage syndrome. Clin. Immunol. Immunopathol., 82: 43-48, 1997.[Medline]
  7. Carney J. P., Maser R. S., Olivares H., Davis E. M., Le Beau M., Yates J. R., 3rd, Hays L., Morgan W. F., Petrini J. H. The hMRE11/hRAD50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell, 93: 477-486, 1998.[Medline]
  8. Varon R., Vissinga C., Platzer M., Cerosaletti K. M., Chrzanowska K. H., Saar K., Beckmann G., Seemanova E., Cooper P. R., Nowak N. J., Stumm M., Weemaes C. M., Gatti R. A., Wilson R. K., Digweed M., Rosenthal A., Sperling K., Concannon P., Reis A. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell, 93: 467-476, 1998.[Medline]
  9. Matsuura S., Vissinga C., Platzer M., Cerosaletti K. M., Chrzanowska K. H., Saar K., Beckmann G., Seemanova E., Cooper P. R., Nowak N. J., Stumm M., Weemaes C. M., Gatti R. A., Wilson R. K., Digweed M., Rosenthal A., Sperling K., Concannon P., Reis A. Positional cloning of the gene for Nijmegen breakage syndrome. Nat. Genet., 19: 179-181, 1998.[Medline]
  10. Maser R. S., Monsen K. J., Nelms B. E., Petrini J. H. hMRE11 and hRAD50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell. Biol., 17: 6087-6096, 1997.[Abstract]
  11. Nugent C. I., Bosco G., Ross L. O., Evans S. K., Salinger A. P., Moore J. K., Haber J. E., Lundblad V. Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol., 8: 657-660, 1998.[Medline]
  12. Le S., Moore J. K., Haber J. E., Greider C. W. RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics, 152: 143-152, 1999.[Abstract/Free Full Text]
  13. Peters A. H., Plug A. W., van Vugt M. J., de Boer P. A drying-down technique for the spreading of mammalian meiocytes from the male and female germline. Chromosome Res., 5: 66-68, 1997.[Medline]
  14. Cardoso M. C., Leonhardt H., Nadal-Ginard B. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell, 74: 979-992, 1993.[Medline]
  15. Marciniak R. A., Lombard D. B., Johnson F. B., Guarente L. Nucleolar localization of the Werner syndrome protein in human cells. Proc. Natl. Acad. Sci. USA, 95: 6887-6892, 1998.[Abstract/Free Full Text]
  16. Lammers J. H., Offenberg H. H., van Aalderen M., Vink A. C., Dietrich A. J., Heyting C. The gene encoding a major component of the lateral elements of synaptonemal complexes of the rat is related to X-linked lymphocyte-regulated genes. Mol. Cell. Biol., 14: 1137-1146, 1994.[Abstract/Free Full Text]
  17. LaMorte V. J., Dyck J. A., Ochs R. L., Evans R. M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA, 95: 4991-4996, 1998.[Abstract/Free Full Text]
  18. Grande M. A., van der Kraan I., van Steensel B., Schul W., de The H., van der Voort H. T., de Jong L., van Driel R. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell. Biochem., 63: 280-291, 1996.[Medline]
  19. Ishov A. M., Maul G. G. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol., 134: 815-826, 1996.[Abstract/Free Full Text]
  20. Korioth F., Maul G. G., Plachter B., Stamminger T., Frey J. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res., 229: 155-158, 1996.[Medline]
  21. Yeager T. R., Neumann A. A., Englezou A., Huschtscha L. I., Noble J. R., Reddel R. R. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res., 59: 4175-4179, 1999.[Abstract/Free Full Text]
  22. Johnson F. B., Lombard D. B., Neff N. F., Mastrangelo M-A., Dewolf W., Ellis N. A., Marciniak R. A., Yin Y., Jaenisch R., Guarente L. Association of the Bloom Syndrome protein with topoisomerase III{alpha} in somatic and meiotic cells. Cancer Res., 60: 1162-1167, 2000.[Abstract/Free Full Text]
  23. Goedecke W., Eijpe M., Offenberg H. H., van Aalderen M., Heyting C. MRE11 and Ku70 interact in somatic cells, but are differentially expressed in early meiosis. Nat. Genet., 23: 194-198, 1999.[Medline]
  24. Prowse K. R., Greider C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA, 92: 4818-4822, 1995.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Virol.Home page
M. H. Luo, K. Rosenke, K. Czornak, and E. A. Fortunato
Human Cytomegalovirus Disrupts both Ataxia Telangiectasia Mutated Protein (ATM)- and ATM-Rad3-Related Kinase-Mediated DNA Damage Responses during Lytic Infection
J. Virol., February 15, 2007; 81(4): 1934 - 1950.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yang, J.-H. Jeong, A. L. Brown, C.-H. Lee, P. P. Pandolfi, J. H. Chung, and M. K. Kim
Promyelocytic Leukemia Activates Chk2 by Mediating Chk2 Autophosphorylation
J. Biol. Chem., September 8, 2006; 281(36): 26645 - 26654.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. J. Luciani, D. Depetris, Y. Usson, C. Metzler-Guillemain, C. Mignon-Ravix, M. J. Mitchell, A. Megarbane, P. Sarda, H. Sirma, A. Moncla, et al.
PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase
J. Cell Sci., June 15, 2006; 119(12): 2518 - 2531.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. E. Cohen, S. E. Pollack, and J. W. Pollard
Genetic Analysis of Chromosome Pairing, Recombination, and Cell Cycle Control during First Meiotic Prophase in Mammals
Endocr. Rev., June 1, 2006; 27(4): 398 - 426.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. J. Chiang, M.-L. Nguyen, S. Gurunathan, P. Kaminker, L. Tessarollo, J. Campisi, and R. J. Hodes
Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice.
Mol. Cell. Biol., March 1, 2006; 26(6): 2037 - 2043.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. H. Stracker, D. V. Lee, C. T. Carson, F. D. Araujo, D. A. Ornelles, and M. D. Weitzman
Serotype-Specific Reorganization of the Mre11 Complex by Adenoviral E4orf3 Proteins
J. Virol., June 1, 2005; 79(11): 6664 - 6673.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Eladad, T.-Z. Ye, P. Hu, M. Leversha, S. Beresten, M. J. Matunis, and N. A. Ellis
Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification
Hum. Mol. Genet., May 15, 2005; 14(10): 1351 - 1365.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. W. Ching, G. Dellaire, C. H. Eskiw, and D. P. Bazett-Jones
PML bodies: a meeting place for genomic loci?
J. Cell Sci., March 1, 2005; 118(5): 847 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Nabetani, O. Yokoyama, and F. Ishikawa
Localization of hRad9, hHus1, hRad1, and hRad17 and Caffeine-sensitive DNA Replication at the Alternative Lengthening of Telomeres-associated Promyelocytic Leukemia Body
J. Biol. Chem., June 11, 2004; 279(24): 25849 - 25857.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kurki, L. Latonen, and M. Laiho
Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization
J. Cell Sci., October 1, 2003; 116(19): 3917 - 3925.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. R. Davalos and J. Campisi
Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks
J. Cell Biol., September 29, 2003; 162(7): 1197 - 1209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Cerosaletti and P. Concannon
Nibrin Forkhead-associated Domain and Breast Cancer C-terminal Domain Are Both Required for Nuclear Focus Formation and Phosphorylation
J. Biol. Chem., June 6, 2003; 278(24): 21944 - 21951.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Wu, X. Jiang, W.-H. Lee, and P.-L. Chen
Assembly of Functional ALT-associated Promyelocytic Leukemia Bodies Requires Nijmegen Breakage Syndrome 1
Cancer Res., May 15, 2003; 63(10): 2589 - 2595.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. de Jager and R. Kanaar
Genome instability and Rad50S: subtle yet severe
Genes & Dev., September 1, 2002; 16(17): 2173 - 2178.
[Full Text] [PDF]


Home page
Genes Dev.Home page
C. F. Bender, M. L. Sikes, R. Sullivan, L. E. Huye, M. M. Le Beau, D. B. Roth, O. K. Mirzoeva, E. M. Oltz, and J. H. J. Petrini
Cancer predisposition and hematopoietic failure in Rad50S/S mice
Genes & Dev., September 1, 2002; 16(17): 2237 - 2251.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
T. M. Nakamura, B. A. Moser, and P. Russell
Telomere Binding of Checkpoint Sensor and DNA Repair Proteins Contributes to Maintenance of Functional Fission Yeast Telomeres
Genetics, August 1, 2002; 161(4): 1437 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Hu, S. Beresten, A. van Brabant, T.-Z. Ye, P.-P. Pandolfi, F. B. Johnson, L. Guarente, and N. A. Ellis
Evidence for BLM and Topoisomerase III{{alpha}} interaction in genomic stability
Hum. Mol. Genet., June 1, 2001; 10(12): 1287 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. M. Taylor, J. S. Moghraby, J. H. Lees, B. Smit, P. B. Moens, and A. R. Lehmann
Characterization of a Novel Human SMC Heterodimer Homologous to the Schizosaccharomyces pombe Rad18/Spr18 Complex
Mol. Biol. Cell, June 1, 2001; 12(6): 1583 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. P. Pandolfi
Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia
Hum. Mol. Genet., April 1, 2001; 10(7): 769 - 775.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. de Jager, M. L. G. Dronkert, M. Modesti, C. E. M. T. Beerens, R. Kanaar, and D. C. van Gent
DNA-binding and strand-annealing activities of human Mre11: implications for its roles in DNA double-strand break repair pathways
Nucleic Acids Res., March 15, 2001; 29(6): 1317 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. McIlrath, S. D. Bouffler, E. Samper, A. Cuthbert, A. Wojcik, I. Szumiel, P. E. Bryant, A. C. Riches, A. Thompson, M. A. Blasco, et al.
Telomere Length Abnormalities in Mammalian Radiosensitive Cells
Cancer Res., February 1, 2001; 61(3): 912 - 915.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
O. K. Mirzoeva and J. H. J. Petrini
DNA Damage-Dependent Nuclear Dynamics of the Mre11 Complex
Mol. Cell. Biol., January 1, 2001; 21(1): 281 - 288.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lombard, D. B.
Right arrow Articles by Guarente, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lombard, D. B.
Right arrow Articles by Guarente, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation